Maurer M - Search Results

1

Soluble IgE-binding factors in the serum of food-allergic patients: Possible pathophysiological role of soluble FcεRI as protective factor.

Steinert C, Moñino-Romero S, Butze M, Scheffel J, Dölle-Bierke S, Dobbertin-Welsch J, Beyer K, Maurer M, Altrichter S. Steinert C, et al. Among authors: maurer m. Clin Transl Allergy. 2023 Feb;13(2):e12222. doi: 10.1002/clt2.12222. Clin Transl Allergy. 2023. PMID: 36825516 Free PMC article.

2

Acquired cold urticaria: clinical picture and update on diagnosis and treatment.

Siebenhaar F, Weller K, Mlynek A, Magerl M, Altrichter S, Vieira Dos Santos R, Maurer M, Zuberbier T. Siebenhaar F, et al. Among authors: maurer m. Clin Exp Dermatol. 2007 May;32(3):241-5. doi: 10.1111/j.1365-2230.2007.02376.x. Epub 2007 Mar 13. Clin Exp Dermatol. 2007. PMID: 17355280 Review.

3

Matrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients?

Altrichter S, Boodstein N, Maurer M. Altrichter S, et al. Among authors: maurer m. Allergy. 2009 Apr;64(4):652-6. doi: 10.1111/j.1398-9995.2008.01799.x. Allergy. 2009. PMID: 19317840

4

[Chronic urticaria. Prevalence, course, prognostic factors and impact].

Weller K, Altrichter S, Ardelean E, Krause K, Magerl M, Metz M, Siebenhaar F, Maurer M. Weller K, et al. Among authors: maurer m. Hautarzt. 2010 Sep;61(9):750-7. doi: 10.1007/s00105-010-1933-8. Hautarzt. 2010. PMID: 20694454 German.

5

Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study.

Krause K, Weller K, Stefaniak R, Wittkowski H, Altrichter S, Siebenhaar F, Zuberbier T, Maurer M. Krause K, et al. Among authors: maurer m. Allergy. 2012 Jul;67(7):943-50. doi: 10.1111/j.1398-9995.2012.02843.x. Epub 2012 May 15. Allergy. 2012. PMID: 22583335 Clinical Trial.

6

Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge.

Hawro T, Saluja R, Weller K, Altrichter S, Metz M, Maurer M. Hawro T, et al. Among authors: maurer m. Allergy. 2014 Jan;69(1):113-7. doi: 10.1111/all.12316. Epub 2013 Nov 20. Allergy. 2014. PMID: 24251414

7

Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels.

Altrichter S, Hawro T, Hänel K, Czaja K, Lüscher B, Maurer M, Church MK, Baron JM. Altrichter S, et al. Among authors: maurer m. J Eur Acad Dermatol Venereol. 2016 Mar;30(3):454-5. doi: 10.1111/jdv.12831. Epub 2014 Nov 4. J Eur Acad Dermatol Venereol. 2016. PMID: 25371135 No abstract available.

8

The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision.

Magerl M, Altrichter S, Borzova E, Giménez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P, Meshkova RY, Zuberbier T, Metz M, Maurer M. Magerl M, et al. Among authors: maurer m. Allergy. 2016 Jun;71(6):780-802. doi: 10.1111/all.12884. Epub 2016 Apr 6. Allergy. 2016. PMID: 26991006

9

Atopic predisposition in cholinergic urticaria patients and its implications.

Altrichter S, Koch K, Church MK, Maurer M. Altrichter S, et al. Among authors: maurer m. J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2060-2065. doi: 10.1111/jdv.13765. Epub 2016 Jun 21. J Eur Acad Dermatol Venereol. 2016. PMID: 27324252

10

Skin provocation tests may help to diagnose atopic dermatitis.

Hawro T, Lehmann S, Altrichter S, Fluhr JW, Zuberbier T, Church MK, Maurer M, Metz M. Hawro T, et al. Among authors: maurer m. Allergy. 2016 Dec;71(12):1745-1752. doi: 10.1111/all.12995. Epub 2016 Aug 18. Allergy. 2016. PMID: 27472813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,622 results

Search Page

Filters